Healthcare & Pharma Stocks
Drugmakers and medical device companies — a defensive sector with a regulatory risk all its own.
Healthcare is considered defensive: people do not stop buying medicine when the economy weakens, so revenue is relatively stable across the cycle.
The price of that stability is a risk that does not exist elsewhere — patent expiry. A successful drug produces large profit until the day its patent lapses, after which revenue from it can fall sharply in a short time. That schedule is known in advance and priced in gradually.
A second layer of the sector is medical device companies, which behave more like industrials: equipment replacement cycles, hospital budgets and regulatory approvals.
Across the 12 names in this list that traded today, the average change was -0.91%. ISRG led at 1.90%, and LLY lagged at -2.52%. A spread that wide inside a single theme shows the move is not uniform, and that the companies are worth looking at individually rather than as a category.
Healthcare & Pharma Stocks — the list
- Eli Lilly and Company stock (LLY) — $1,273.72 (-2.52%)
- Johnson & Johnson stock (JNJ) — $263.86 (-1.40%)
- Pfizer Inc stock (PFE) — $30.01 (-1.35%)
- Merck & Co Inc stock (MRK) — $145.27 (-1.34%)
- AbbVie Inc stock (ABBV) — $285.59 (+0.14%)
- UnitedHealth Group Inc stock (UNH) — $418.01 (-1.64%)
- Thermo Fisher Scientific stock (TMO) — $673.74 (-0.41%)
- Abbott Laboratories stock (ABT) — $103.71 (+1.17%)
- Bristol-Myers Squibb Co stock (BMY) — $61.49 (-2.40%)
- Amgen Inc stock (AMGN) — $439.26 (-1.79%)
- Moderna Inc stock (MRNA) — $200.10 (-1.25%)
- Intuitive Surgical Inc stock (ISRG) — $452.29 (+1.90%)
Healthcare & Pharma Stocks — frequently asked questions
Which stocks are in Healthcare & Pharma Stocks?
The list holds 12 securities, among them LLY, JNJ, PFE, MRK, ABBV. Membership is curated by hand rather than taken from a sector label, so the list describes the theme rather than the classification.
How many stocks are in Healthcare & Pharma Stocks?
12 securities, each with its own page carrying a live price, chart, news and risk scoring.
Should I invest in Healthcare & Pharma Stocks?
VAQO is not an investment adviser and makes no recommendations. The list is a research starting point: every name in it carries momentum and risk scoring from a model whose accuracy is published openly, alongside news and community sentiment.
Other themes
- AI Stocks
- Semiconductor Stocks
- Dividend Stocks
- EV Stocks
- Bank Stocks
- Magnificent Seven
- Cybersecurity Stocks
- Israeli Stocks on Wall Street
Lists are curated by hand and are not a recommendation to buy or sell. VAQO is not an investment adviser.
Last updated: 2026-10-25